AN 782 (Memantine Hydrochloride Extended-Release 7 mg)
Pill with imprint AN 782 is Yellow, Capsule-shape and has been identified as Memantine Hydrochloride Extended-Release 7 mg. It is supplied by Amneal Pharmaceuticals LLC.
Memantine is used in the treatment of alzheimer's disease and belongs to the drug class miscellaneous central nervous system agents. There is no proven risk in humans during pregnancy. Memantine 7 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for AN 782
Memantine Hydrochloride Extended-Release
- Imprint
- AN 782
- Strength
- 7 mg
- Color
- Yellow
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Miscellaneous central nervous system agents
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals LLC
- National Drug Code (NDC)
- 65162-0782
- Inactive Ingredients
-
silicon dioxide,
ethylcelluloses,
hypromelloses,
sucrose,
corn starch,
magnesium silicate,
triethyl citrate,
D&C Yellow No. 10,
gelatin,
ferric oxide yellow,
titanium dioxide,
FD&C Blue No. 1,
FD&C Blue No. 2,
FD&C Red No. 40,
ferrosoferric oxide,
butyl alcohol,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
Related Images for "AN 782"
More about memantine
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 57 Reviews
- Drug class: miscellaneous central nervous system agents
Consumer resources
- Patient Information
- Memantine (Advanced Reading)
- Memantine Tablets
- Memantine Extended-Release Capsules
- Memantine Solution
- Other brands
- Namenda, Namenda XR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.